Femme et Homme
- | Pays :
- Netherlands
- United States
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to evaluate the safety and efficacy of siltuximab in participants with relapsed (the return of a disease or the signs and symptoms of a disease after a period of improvement.) or refractory (cancer that does not respond to treatment) multiple myeloma (a type of cancer that begins in plasma cells [white blood cells that produce antibodies]).
Critère d'inclusion
- Multiple myeloma